Variables | Number of patients (n) | Mean ± SD or % |
---|---|---|
Hg (mg/dl) | 114 | 11.80 ± 2.94 |
WBC (× 103/mm3) | 114 | 7.40 ± 3.60 |
PLT (× 103/mm3) | 114 | 259.88 ± 134.24 |
ESR (mm/hour) | 44 | 56.22 ± 36.51 |
Serum albumin (mg/dl) | 53 | 2.77 ± 0.64 |
Creatinine (mg/dl) | 114 | 2.45 ± 2.17 |
CKD-EPI eGFR (ml/min) | 114 | 58.36 ± 42.31 |
Urea (mg/dl) | 114 | 81.79 ± 52.42 |
Urine proteins (g/24 h) | 114 | 4.47 ± 2.24 |
ANA (positive) | 85 | 74.6 |
Anti-dsDNA (positive) | 31 | 27.2 |
C3 (low) | 44 | 38.6 |
C4 (low) | 38 | 33.3 |
LA (positive) | 11 | 9.6 |
SBP at onset of LN (mmHg) | 114 | 129.52 ± 19.96 |
DBP at onset of LN (mmHg) | 114 | 82.59 ± 14.32 |
Lupus class/kidney biopsy (%) | 71 | |
Class II | 3(4.2) | |
Class III | 20(28.2) | |
Class IV | 28(39.4) | |
Class V | 5(7.0) | |
Class III/V | 7(9.9) | |
Class IV/V | 8(11.3) | |
CKD-EPI eGFR Stages (%) | 114 | |
Stage 1 | 25(21.9) | |
Stage 2 | 19(16.7) | |
Stage 3 | 34(29.8) | |
Stage 4 | 20(17.5) | |
Stage 5 | 16(14.0) | |
Mean follow up period (months) | 114 | 27.93 ± 17.15 |